NCCN Guidelines Insights: Survivorship, Version 2.2020.
Journal
Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
entrez:
7
8
2020
pubmed:
7
8
2020
medline:
5
11
2021
Statut:
ppublish
Résumé
The NCCN Guidelines for Survivorship provide screening, evaluation, and treatment recommendations for consequences of adult-onset cancer and its treatment, with the goal of helping healthcare professionals who work with survivors, including those in primary care. The guidelines also provide recommendations to help clinicians promote physical activity, weight management, and proper immunizations in survivors and facilitate care coordination to ensure that all of the survivors' needs are addressed. These NCCN Guidelines Insights summarize additions and changes made to the guidelines in 2020 regarding cardiovascular disease risk assessment and screening for subsequent primary malignancies.
Identifiants
pubmed: 32755975
doi: 10.6004/jnccn.2020.0037
pii: jnccnGLINS1808
pmc: PMC7785060
mid: NIHMS1658244
doi:
pii:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1016-1023Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK056336
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA215134
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA246659
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Références
J Clin Oncol. 2014 Dec 10;32(35):4004-11
pubmed: 25267739
JAMA. 2010 Jul 14;304(2):172-9
pubmed: 20628130
CA Cancer J Clin. 2019 Sep;69(5):363-385
pubmed: 31184787
J Natl Cancer Inst. 2010 Jul 21;102(14):1083-95
pubmed: 20634481
J Clin Oncol. 2012 Jul 10;30(20):2552-8
pubmed: 22665546
Cancer. 2016 Oct;122(19):3075-86
pubmed: 27377470
Cancer Lett. 2015 Dec 1;369(1):152-66
pubmed: 26319898
BMJ. 2016 Mar 02;352:i851
pubmed: 26936410
J Clin Oncol. 2016 Apr 1;34(10):1122-30
pubmed: 26834065
Cancer. 2014 Sep 1;120(17):2735-41
pubmed: 24842808
Lancet Oncol. 2014 Mar;15(3):333-42
pubmed: 24525202
Lancet Oncol. 2011 Apr;12(4):353-60
pubmed: 21454129
Ann Oncol. 2017 Feb 1;28(2):400-407
pubmed: 27831506
JAMA. 2019 Aug 20;322(7):652-665
pubmed: 31429903
J Clin Oncol. 2014 Dec 10;32(35):3989-95
pubmed: 25385740
J Clin Oncol. 2016 Feb 20;34(6):611-35
pubmed: 26644543
Circ Res. 2013 Aug 30;113(6):754-64
pubmed: 23989717
CA Cancer J Clin. 2014 Jul-Aug;64(4):252-71
pubmed: 24890451
Pediatr Blood Cancer. 2020 Feb;67(2):e28047
pubmed: 31736278
J Clin Oncol. 2015 Oct 1;33(28):3096-104
pubmed: 26240221
Circulation. 2014 Oct 28;130(18):e157-9
pubmed: 25462826
Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1033-40
pubmed: 19336557
J Clin Oncol. 2015 Feb 1;33(4):340-8
pubmed: 25534386
Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):170-81
pubmed: 20056636
Nat Rev Clin Oncol. 2013 May;10(5):289-301
pubmed: 23529000
Ann Oncol. 2014 Oct;25(10):2073-2079
pubmed: 25185241
MMWR Morb Mortal Wkly Rep. 2011 Mar 11;60(9):269-72
pubmed: 21389929
BJU Int. 2016 Aug;118(2):221-9
pubmed: 26074405
JAMA Netw Open. 2018 Sep 7;1(5):e181999
pubmed: 30646145
Med Oncol. 2014 May;31(5):943
pubmed: 24696219
N Engl J Med. 2016 Oct 13;375(15):1457-1467
pubmed: 27732808
J Clin Oncol. 2014 Oct 10;32(29):3284-90
pubmed: 25185089
J Am Coll Cardiol. 2015 Sep 8;66(10):1160-78
pubmed: 26337996
J Geriatr Oncol. 2020 Mar;11(2):316-319
pubmed: 31575519
J Cancer Surviv. 2013 Jun;7(2):253-61
pubmed: 23417882
Circulation. 2013 Mar 26;127(12):1270-5
pubmed: 23509058
JAMA Oncol. 2018 Jun 1;4(6):832-836
pubmed: 29167866
Circulation. 2015 Nov 3;132(18):e218-20
pubmed: 26527696
J Natl Cancer Inst. 2006 Jan 4;98(1):15-25
pubmed: 16391368
J Med Genet. 2020 Aug;57(8):528-530
pubmed: 31511339
N Engl J Med. 2015 Dec 24;373(26):2499-511
pubmed: 26699166
J Clin Oncol. 2018 Jul 10;36(20):2078-2087
pubmed: 29847298
J Clin Oncol. 2007 May 20;25(15):2100-6
pubmed: 17513816
N Engl J Med. 2013 Mar 14;368(11):1055-6
pubmed: 23484833
J Clin Oncol. 2012 Oct 20;30(30):3734-45
pubmed: 23008293
Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1029-36
pubmed: 27371756
Int J Cancer. 2015 Aug 15;137(4):940-8
pubmed: 25650288
Lancet. 2019 Sep 21;394(10203):1041-1054
pubmed: 31443926
Cancer Med. 2018 Oct;7(10):4952-4963
pubmed: 30220107
J Clin Oncol. 2017 May 1;35(13):1395-1402
pubmed: 28301264
Ann Intern Med. 2012 Jun 5;156(11):757-66, W-260
pubmed: 22665813
Ann Surg Oncol. 2019 Oct;26(10):3025-3031
pubmed: 31342359
J Clin Oncol. 2016 Dec;34(34):4116-4124
pubmed: 27863195
Natl Vital Stat Rep. 2019 Jun;68(6):1-77
pubmed: 32501203
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837
Int J Med Sci. 2012;9(2):163-73
pubmed: 22275855
Circulation. 2019 May 21;139(21):e997-e1012
pubmed: 30955352
J Clin Oncol. 2015 Apr 10;33(11):1243-51
pubmed: 25732167
N Engl J Med. 2013 Mar 14;368(11):987-98
pubmed: 23484825